> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Wants Comments on Innovative Clinical Trials
- URL: https://www.fdaweb.com/fda-wants-comments-on-innovative-clinical-trials/
- Published: 2023-10-17T12:00:00.000Z
- Updated: 2026-09-14T14:13:31.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5155583

FDA says CDER is soliciting comments on the barriers and facilitators to incorporating successful or promising innovative clinical trial approaches in drug development programs. An online [notice](https://www.regulations.gov/document/FDA-2023-N-4489-0001?utm%5Fmedium=email&utm%5Fsource=govdelivery) lists questions the agency says could be considered in responses.

“Comments submitted to this public docket will inform CDER’s future work related to clinical trial innovation and the planning of an upcoming public workshop sponsored by CDER and Duke-Margolis Center for Health Policy on 3/19-20/2024,” it says.